Zobrazeno 1 - 10
of 36
pro vyhledávání: '"M V, PETERS"'
Publikováno v:
Современная онкология, Vol 16, Iss 3, Pp 94-96 (2014)
In a recent randomized, double-blind, phase III clinical trials among patients with metastatic castration-resistant prostate cancer (CRPC) progressing on androgen-deprivation therapy or after docetaxel chemotherapy, abiraterone acetate was shown to s
Externí odkaz:
https://doaj.org/article/91d92c9ddabe44a382eedf126d651646
Autor:
M. V. Peters, V. B. Matveev, E. K. Ginter, P. V. Apanovich, A. V. Karpukhin, B. Sh. Kamolov, N. V. Apanovich
Publikováno v:
Doklady Biochemistry and Biophysics. 478:14-17
The main mechanisms of pathogenesis of clear cell renal cell carcinoma (CCRCC) are realized through the PI3K-AKT-mTOR and Ras-RAF-ERK signaling pathways. Targeted therapy is directed primarily at the genes and their encoded products that are componen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::816f90e0e0a6646347e3237ceaaf991d
https://doi.org/10.1134/s1607672918010040
https://doi.org/10.1134/s1607672918010040
Autor:
N. V. Apanovich, Vsevolod Matveev, B. Sh. Kamolov, A. S. Markova, A. V. Karpukhin, P. V. Apanovich, M. V. Peters, A. A. Korotaeva
Publikováno v:
Onkourologiâ, Vol 12, Iss 4, Pp 16-20 (2016)
Background. On the pace of growth in Russia, renal carcinoma takes the 1st place. Approximately one third of patients at time of diagnosis have distant metastases, and relapse of the disease occurs in 30–40 %. Renal carcinoma does not manifest unti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74f1ac560cd7067987be32d36befc80
https://oncourology.abvpress.ru/oncur/article/view/602
https://oncourology.abvpress.ru/oncur/article/view/602
Autor:
N. V. Apanovich, A. S. Markova, P. V. Apanovich, A. V. Karpukhin, M. V. Peters, B. Sh. Kamolov, V. B. Matveev
Publikováno v:
Bulletin of experimental biology and medicine. 166(2)
We analyzed association of the levels of VEGFA, RAF1, and mTOR gene expression in the tissue of clear-cell renal cell carcinoma (ccRCC) with tumor metastasizing. Significant association with metastases was found only for VEGFA gene: OR=6.641, 95%CI=2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac8f7abf65a2de70922ee7e62c73f63
https://pubmed.ncbi.nlm.nih.gov/30488209
https://pubmed.ncbi.nlm.nih.gov/30488209
Publikováno v:
Onkourologiâ, Vol 11, Iss 3, Pp 24-33 (2015)
Objective: to assess the role of palliative nephrectomy in disseminated kidney cancer patients planned to undergo targeted antiangiogenic treatment. Subjects and methods . The investigation included data on 83 patients with T1-4N0 / +M1 disseminated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5a6fe030c070d2b1077e16fa4ce912
https://oncourology.abvpress.ru/oncur/article/view/484
https://oncourology.abvpress.ru/oncur/article/view/484
Autor:
A. S. Markova, S. B. Polikarpova, B. Sh. Kamolov, Ya. V. Gridneva, S. A. Kalinin, M. V. Peters, V. B. Matveev
Publikováno v:
Onkourologiâ, Vol 11, Iss 2, Pp 77-84 (2015)
Objective: to estimate overall survival (OS) rates in patients with metastatic castration-resistant prostate cancer (mCRPC), who have received currently available drugs and to identify the predictors of OS. Subjects and methods. The case histories of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf68386fbbded51448fe808fe68b241
https://oncourology.abvpress.ru/oncur/article/view/457
https://oncourology.abvpress.ru/oncur/article/view/457
Autor:
M. I. Volkova, I. Ya. Skvortsov, A. V. Klimov, V. A. Chernyaev, M. I. Komarov, V. B. Matveev, M. V. Peters
Publikováno v:
Onkourologiâ, Vol 10, Iss 3, Pp 22-30 (2014)
Objective: to analyze the impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal carcinoma.Subjects and methods. Four hundred and fifty-three patients with pT1–3aN0M0 renal cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::726643ae0fe89958bc2659bd0c7d3d8c
https://oncourology.abvpress.ru/oncur/article/view/374
https://oncourology.abvpress.ru/oncur/article/view/374
Publikováno v:
Onkourologiâ, Vol 7, Iss 3, Pp 59-65 (2014)
Onkourologiâ, Vol 7, Iss 3, Pp 129-131 (2014)
Onkourologiâ, Vol 7, Iss 3, Pp 129-131 (2014)
The paper describes a clinical case of a local recurrence of tubulocystic carcinoma (TCC) in a 46-year-old man, a relatively good course (the relapse occurred after 4 years), who has been successfully operated on and is being followed up. This diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::426a100fa878b1e17ecbebdc3a76560c
http://oncourology.abvpress.ru/index.php/oncur/article/view/235
http://oncourology.abvpress.ru/index.php/oncur/article/view/235
Publikováno v:
Onkourologiâ, Vol 5, Iss 1, Pp 27-31 (2014)
Objective: to study the results of sparing cystectomy in patients with urinary bladder cancer (UBC).Subjects and methods. The study has covered 82 patients with transitional-cell UBC (T1-4aN0M0) who received radiotherapy (RT) and thenunderwent radica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::abeb6d1325dc435f135b17d7264c70ac
https://oncourology.abvpress.ru/oncur/article/view/181
https://oncourology.abvpress.ru/oncur/article/view/181
Autor:
M. V. Peters, V. E. Shevchenko, V. B. Matveev, M. I. Volkova, S. A. Kalinin, D. M. Mikhailenko, D. V. Zaletayev
Publikováno v:
Onkourologiâ, Vol 7, Iss 4, Pp 24-31 (2014)
Objective: to study the prognostic value of alterations in the VHL gene and the plasma markers hVEGF, hVEGFR2, and hVEGFR3 in patients with metastatic kidney cancer (KC) who receive targeted therapy.Subjects and methods. Paraffin blocks from 22 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0522d78c5d96cf8fda799dc68e92a7cf
https://oncourology.abvpress.ru/oncur/article/view/185
https://oncourology.abvpress.ru/oncur/article/view/185